Search

Search Results
Results 10231 - 10240 of 17271 for Active treatment
  • Madopar
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Madopar intended for persons living in Australia.
  • Lamisil Tablets
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Lamisil Tablets intended for persons living in Australia.
  • Pulmozyme
    Drug - 12 Dec 2025
    Consumer Medicine Information (CMI) about Pulmozyme intended for persons living in Australia.
  • Izervay
    Drug - 9 Dec 2025
    Consumer Medicine Information (CMI) about Izervay intended for persons living in Australia.
  • Tobramycin Viatris
    Drug - 2 Dec 2025
    Consumer Medicine Information (CMI) about Tobramycin Viatris intended for persons living in Australia.
  • Blocking a ‘gerozyme’ reverses cartilage loss in mice
    News - 28 Nov 2025
    An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee joints of old mice, a Stanford Medicine-led study has found.
  • Entecavir Viatris
    Drug - 28 Nov 2025
    Consumer Medicine Information (CMI) about Entecavir Viatris intended for persons living in Australia.
  • Voltaren
    Drug - 26 Nov 2025
    Consumer Medicine Information (CMI) about Voltaren intended for persons living in Australia.
  • New skin-permeable polymer delivers insulin without needles
    News - 25 Nov 2025
    Innovative zwitterionic polymer facilitates insulin absorption through the skin, offering a painless alternative to injections for diabetes management.
  • Replagal
    Drug - 25 Nov 2025
    Consumer Medicine Information (CMI) about Replagal intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback